Prepare for Questions About Xolair for Food Allergies

May 2024

Omalizumab (Xolair) is the first monoclonal antibody FDA-approved for patients with food allergies.

It joins the approved oral immunotherapy Palforzia...a peanut allergen powder for desensitization in patients with peanut allergy.

But omalizumab blocks IgE...to reduce allergic reactions from accidental exposure to one or more foods, such as peanuts, eggs, or milk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote